Table 1.
Characteristics of Patients With COVID-19 Illness by the Lack of Sense of Smell.
| Characteristics | Anosmia*,N = 162 | No Anosmia*,N = 324 | P-Value |
|---|---|---|---|
| Demographics | |||
| Age, years (±SE) | 53 (±1.2) | 59 (±1.0) | <0.001 |
| Gender, N (%) women | 81 (50) | 144 (46) | 0.4 |
| Race/ethnicity, N (%) | 0.06 | ||
| White | 23 (14) | 22 (7) | |
| Black | 55 (34) | 133 (42) | |
| Latino | 56 (34) | 102 (32) | |
| Asian | 5 (3) | 5 (2) | |
| Unknown | 24 (15) | 52(17) | |
| Reported symptoms | |||
| Ageusia*, N (%) | 148 (91) | 92 (29) | <0.001 |
| Fever*, N (%) | 116 (71) | 178 (57) | <0.01 |
| Body aches*, N (%) | 111 (69) | 128 (41) | <0.001 |
| Cough*, N (%) | 112 (69) | 173 (55) | <0.01 |
| Sore throat*, N (%) | 46 (28) | 61 (20) | 0.03 |
| Belly ache*, N (%) | 38 (24) | 50 (16) | 0.06 |
| Shortness of breath*, N (%) | 50 (31) | 105 (34) | 0.6 |
| Diarrhea*, N (%) | 82 (50) | 110 (35) | <0.01 |
| Fatigue or weakness*, N (%) | 135 (82) | 183 (60) | <0.001 |
| Headache*, N (%) | 30 (19) | 35 (11) | 0.03 |
| BMI▲, kg/m2 (IQR) | 31 (27–38) | 30 (26–35) | 0.1 |
| Number of days from SARS-CoV-2 test to the phone interview (±SE) | 46·4 (±1.4) | 49·6 (±1.0) | 0.09 |
| Patient past medical history | |||
| History of hypertension▲, N (%) | 64 (39) | 164 (52) | 0.006 |
| History of hypercholesterolemia▲, N (%) | 44 (27) | 119 (38) | 0.02 |
| Laboratory markers at the time of SARS-CoV-2 test | |||
| Eosinophil counts▲, K/μL (±SE) | 0.02 (±0.004) | 0·05 (±0.006) | 0.01 |
| Fibrinogen▲, mg/dL (±SE) | 687 (±20.0) | 640 (±13.0) | 0.049 |
| Lactic dehydrogenase▲, U/L (±SE) | 426 (±13.7) | 411 (±14.2) | 0.4 |
| Outcomes | |||
| Length of emergency department or hospital stay▲, days (IQR) | 4 (2–8) | 6 (3–10) | 0.002 |
| Admission to ICU▲, N (%) | 18 (11) | 32 (10) | 0.8 |
| Endotracheal intubations▲, N (%) | 10 (6) | 21 (7) | 0.8 |
*Patient reported, ▲ Extracted and verified through medical record data extraction and review.